Characteristics and limitations of national antimicrobial surveillance according to sales and claims data.
<h4>Purpose</h4>Antimicrobial use (AMU) is estimated at the national level by using sales data (S-AMU) or insurance claims data (C-AMU). However, these data might be biased by generic drugs that are not sold through wholesalers (direct sales) and therefore not recorded in sales databases...
Saved in:
Main Authors: | Yoshiki Kusama, Yuichi Muraki, Chika Tanaka, Ryuji Koizumi, Masahiro Ishikane, Daisuke Yamasaki, Masaki Tanabe, Norio Ohmagari |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5e3b869556c34f9db3e7a75ce095fe62 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
by: Yoshiaki Gu, et al.
Published: (2021) -
Temporal changes in trauma according to alcohol sale restrictions during the South African national COVID-19 lockdown
by: Daniel J. van Hoving, et al.
Published: (2021) -
Claims on Ready-to-Eat Cereals: Are Those With Claims Healthier?
by: María Parra-Murillo, et al.
Published: (2021) -
Suggestion of a simpler and faster influenza-like illness surveillance system using 2014–2018 claims data in Korea
by: HeeKyoung Choi, et al.
Published: (2021) -
The Sale with Repurchase Clause
by: Urs,Ilie
Published: (2010)